Answers are grounded in this paper and cite their sources.
Retrospective case-control study demonstrates high diagnostic accuracy of the Lead I sign in adults aged 30–70, highlighting its value as a simple screening tool for COPD.
Background Chronic Obstructive Pulmonary Disease (COPD) affects millions worldwide, yet early diagnosis remains challenging due to limited availability of pulmonary function testing. The Lead I sign on electrocardiogram has been anecdotally observed in COPD patients. Objective To determine the association between the presence of Lead I sign on ECG and COPD diagnosis in patients aged 30–70 years. Methods This retrospective case-control study included 201 patients (96 with positive Lead I sign, 105 with negative Lead I sign). Lead I sign was defined as ≥ 2 criteria: isoelectric P wave, QRS amplitude < 1.5 mm, and T wave amplitude < 0.5 mm in lead I. COPD diagnosis was confirmed through pulmonary function testing and clinical documentation. Results Among patients with positive Lead I sign, 80 (83.3%) had COPD, while only 12 (11.4%) with negative Lead I sign had COPD (p < 0.001). The Lead I sign demonstrated sensitivity 87.0%, specificity 85.3%, positive predictive value 83.3%, and negative predictive value 88.6%. Conclusion The Lead I sign shows a strong association with COPD diagnosis with excellent diagnostic performance, suggesting potential utility as an accessible screening tool.
No takes yet. Share an insight, caveat, or question.
Panyala et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: